Evidence map›Paper›PMID 42787459›Full record

ArticleFrontiers in neurology2026

Safety and efficacy of endovascular treatment for progressive large vessel occlusion stroke presenting 24-72 h after onset: a propensity score-matched analysis.

Shi-Qian Guo, Yuan-Zhan Guo, Shi-Dun Chen, Zai-Hang Zhang, Shuang Pei, Xing-Chen Qiu, Rong-Yi Liu, Bing Guo, Wan-Li Bao, Jing Zhou and 2 more

Abstract read
In one paragraph

Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Shi-Qian GuoDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Yuan-Zhan GuoDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Shi-Dun ChenDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Zai-Hang ZhangDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Shuang PeiDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Xing-Chen QiuDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Rong-Yi LiuDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Bing GuoDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Wan-Li BaoDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Jing ZhouDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Ning WangDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.
Jun SunDepartment of Neurointervention, Nanyang Central Hospital, Nanyang, Henan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and purpose: To evaluate the efficacy and safety of endovascular treatment (EVT) versus standard medical therapy (SMT) in patients with progressive large vessel occlusion (LVO) presenting 24-72 h after onset. Methods: We retrospectively analyzed patients with progressive LVO and perfusion mismatch (tissue window) between 24 and 72 h after onset. Propensity score matching (PSM) was performed to balance baseline characteristics. The primary outcome was functional independence (modified Rankin Scale [mRS] 0-2) at 90 days. Secondary outcomes included 90-day mortality and symptomatic intracranial hemorrhage (sICH). Results: A total of 164 patients were included (EVT, Conclusion: For progressive LVO patients presenting 24-72 h after onset with favorable perfusion imaging, EVT was associated with improved functional outcomes and lower mortality, without a significant increase in hemorrhage risk. Furthermore, good collateral circulation is a statistically significant factor associated with EVT benefit.

Indexed as

Endovascular ProceduresIschemic StrokeStrokeAgedAged, 80 and overDisease ProgressionFemaleHumansMaleMiddle AgedPropensity ScoreRetrospective StudiesTime FactorsTreatment Outcomeendovascular treatmentprogressive strokepropensity score matchingstandard medical therapysymptomatic intracranial hemorrhage

Identifiers

PMID42787459
PMCPMC13601329

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.